Dr. Peter H. Sayre, MD

Dr. Sayre practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Sayre's NPI, 1841308517, was assigned on August 25, 2006. Dr. Sayre graduated from Rutgers Robert Wood Johnson Medical School in 1990. Dr. Sayre's California license number on file is G73818.

Dr. Sayre's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Sayre's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Sayre to 4 more group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sayre practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sayre's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sayre is board certified in hematology by the American Board of Internal Medicine. Dr. Sayre has a license on file in California.

Dmand AI lists anemia, chronic anemia, chronic leukemia, immune deficiency disease, lymphoma, multiple myeloma, neutropenia and prostate cancer among the conditions Dr. Sayre treats.

CMS data shows 281 Medicare services from Dr. Sayre across 4 procedure codes in 2024, for 84 Medicare patients. Medicare paid $21,821 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 84 Medicare patients who saw Dr. Sayre in 2024. The largest group is 65 to 74, with 43 patients. 68% of them have high cholesterol, and 65% have high blood pressure. 23% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sayre's median patient age at 65, with 44% women.

In 2024, Dr. Sayre wrote 299 Medicare Part D claims for 36 patients. 65% of them were for generic drugs. CMS names the drug for 95 of them, across 5 drugs with 11 or more claims each, at $773,098 in total drug cost. In 2023, CMS named 263 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Sayre for performance year 2024, reported as part of a group. Dr. Sayre accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sayre as offering telehealth.

Dmand AI links 32 papers to Dr. Sayre, published from 2009 to 2025. 2016 was the busiest year, with 6. The most frequent topics are Arachis, Peanut Hypersensitivity and Immunoglobulin E. Dr. Sayre has published most often in J Allergy Clin Immunol. Dr. Sayre's most frequent co-authors are Charalambos I. Andreadis, MD, Lloyd Damon, MD and Karin Gaensler, MD.

CMS Open Payments shows 12 general payments to Dr. Sayre from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. Baxalta US Inc paid the most, $4,302.

Dmand AI lists 1 award for Dr. Sayre, most recently CMS Stage 1 EHR in 2013.

Dr. Sayre graduated from Rutgers Robert Wood Johnson Medical School in 1990.

Dr. Sayre is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.